secwatch.observer — SEC 8-K summary
======================================

Issuer:     X4 Pharmaceuticals, Inc (XFOR)
CIK:        0001501697
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001628280-25-030743
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

X4 Pharmaceuticals stockholders elect R. Keith Woods as director, ratify auditor, approve say-on-pay
--------------------------------------------------------------------------------

- R. Keith Woods elected with 52.2M for, 29.9M withheld; 53.8M broker non-votes.
- Ratification of PwC as auditor: 128.9M for, 6.6M against, 0.4M abstain.
- Non-binding say-on-pay approved: 67.8M for, 12.2M against, 2.0M abstain, 53.8M broker non-votes.
- All three proposals passed at annual meeting held June 9, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025030743/0001628280-25-030743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501697/000162828025030743/xfor-20250611.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-030743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer